Corporation
Gilead Sciences Canada
- Meetings this Parliament
- 47
- With MPs
- 12
- Since Nov 2021
- 107
- Active registrations
- 1
Most recent reported meeting: Sep 22, 2026.
Lobbying by Gilead Sciences Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (corporation) In effect since Apr 2, 2026
Filed by Paul Petrelli, General Manager
Lobbyists
- Bobby Sutherland · Sr. Director, Government Affairs
- Paul Petrelli · General Manager
Institutions they may lobby: CUSMA Secretariat, Canadian Institutes of Health Research (CIHR), Correctional Service of Canada (CSC), Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Immigration, Refugees and Citizenship Canada (IRCC), Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Intergovernmental Affairs Secretariat (IGA), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Senate of Canada, Treasury Board Of Canada Secretariat (TBS)
What they're lobbying on (9)Hide details
- Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations
- Food and Drug regulations as it relates to data protection and the regulation and protection of biopharmaceutical products
- Canada's Drug Agency (CDA) policies as it relates to health economics assessment and recommendations made on new medicines.
- Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations.
- Free Trade agreements as they relate to the biopharmaceutical industry
- Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.
- Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.
- Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
- Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Registration 959600-360912-19. Look it up in the official Registry
Reported meetings
SpreadsheetFiled by Paul Petrelli (50), Christophe Griolet (39), Scott Spencer (9), Melissa Koomey (9).
-
Reported by Scott Spencer · In-house (corporation)
- Earl Dreeshan · Member of Parliament, House of Commons
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Scott Spencer · In-house (corporation)
- Tom Kmiec · Member of Parliament
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Scott Spencer · In-house (corporation)
- Valerie Bradford · Member of Parliament, House of Commons
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Scott Spencer · In-house (corporation)
- Corey Tochor · Member of Parliament
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Scott Spencer · In-house (corporation)
- Tony Baldinelli · Member of Parliament
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Scott Spencer · In-house (corporation)
- Matt Jeneroux · Member of Parliament
Economic DevelopmentHealthIndustryResearch and DevelopmentScience and Technology
-
Reported by Scott Spencer · In-house (corporation)
- Michelle Boudreau · Executive Director, Health Canada (HC)
HealthIndustryResearch and Development
-
Reported by Scott Spencer · In-house (corporation)
- Deliah Bernard · Indigenous Affairs and Policy Advisor, Prime Minister's Office (PMO)
Aboriginal AffairsHealth
-
Reported by Scott Spencer · In-house (corporation)
- Fatima Asghar · Policy Advisor, Health Canada (HC)
HealthIndustryResearch and Development
-
Reported by Christophe Griolet · In-house (corporation)
- Cyndi Jenkins · Chief of Staff to the Minister, Health Canada (HC)
HealthResearch and DevelopmentScience and Technology
-
Reported by Christophe Griolet · In-house (corporation)
- Carol Hughes · Member of Parliament, House of Commons
Aboriginal AffairsHealth
-
Reported by Christophe Griolet · In-house (corporation)
- Anthony Rota · Member of Parliament, House of Commons
Aboriginal AffairsHealth
-
Reported by Christophe Griolet · In-house (corporation)
- Steven Sternthal · Director General, Public Health Agency of Canada (PHAC)
Aboriginal AffairsHealth
-
Reported by Christophe Griolet · In-house (corporation)
- Craig Shankar · Director General, Immigration, Refugees and Citizenship Canada (IRCC)
- Isabelle Buchanan · Policy advisor, Immigration, Refugees and Citizenship Canada (IRCC)
HealthImmigration
-
Reported by Christophe Griolet · In-house (corporation)
- Tom Kmiec · Member of Parliament
- Blaine Calkins · Member of Parliament
- Stephen Ellis · Member of Parliament, House of Commons
- Earl Dreeshan · Member of P, House of Commons
HealthIntellectual PropertyResearch and DevelopmentScience and Technology
-
Reported by Christophe Griolet · In-house (corporation)
- Jennifer O'Connell · Member of Parliament, House of Commons
HealthIndustry
-
Reported by Christophe Griolet · In-house (corporation)
- jaxson Khan · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Laurel Chester · Senior Advisor, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentHealthIndustry
-
Reported by Christophe Griolet · In-house (corporation)
- Colin Deacon · Senator, Senate of Canada
Economic DevelopmentHealthIndustry
-
Reported by Christophe Griolet · In-house (corporation)
- Brian Masse · Member of Parliament Windsor West, House of Commons
HealthIndustryInternational Trade
-
Reported by Christophe Griolet · In-house (corporation)
- Francis Bilodeau · Associate Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Andrea Johnston · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Etienne-Rene Massie · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentHealthIndustry
-
Reported by Christophe Griolet · In-house (corporation)
- Mark Schaan · Senior Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
HealthIndustryIntellectual PropertyResearch and Development
-
Reported by Christophe Griolet · In-house (corporation)
- Wilder Walker-Stewart · Policy Advisor, Health Canada (HC)
- Fatima Asghar · Policy Advisor, Health Canada (HC)
Federal-Provincial RelationsHealthResearch and Development
-
Reported by Christophe Griolet · In-house (corporation)
- Suzy McDonald · Associate Deputy Minister, Finance Canada (FIN)
Economic DevelopmentHealthResearch and DevelopmentScience and Technology
-
Reported by Christophe Griolet · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentResearch and DevelopmentScience and Technology
-
Reported by Christophe Griolet · In-house (corporation)
- Heather Jeffrey · President, Public Health Agency of Canada (PHAC)
- cindy evans · Vice President,, Public Health Agency of Canada (PHAC)
- joel denis · Director General, Public Health Agency of Canada (PHAC)
Federal-Provincial RelationsHealthIndustryResearch and Development
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.